Global Information
회사소개 | 문의

세계의 체외진단(IVD) 시장 예측

In Vitro Diagnostics/IVD Market By Product (Reagent, Instruments, Software, Service), Technique (Immunoassay, Clinical Chemistry, PCR), Application (Hematology, Diabetes, Nephrology, Oncology), End User (Hospital, POC) - Global Forecast To 2024

리서치사 Meticulous Market Research Pvt. Ltd.
발행일 2019년 01월 상품 코드 775912
페이지 정보 영문 301 Pages
가격
US $ 4,175 ₩ 4,748,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스로 편집 및 인쇄가 불가능합니다.
US $ 7,375 ₩ 8,388,000 PDF by E-mail (Global Site License)

주의 : 본 보고서는 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 체외진단(IVD) 시장 예측 In Vitro Diagnostics/IVD Market By Product (Reagent, Instruments, Software, Service), Technique (Immunoassay, Clinical Chemistry, PCR), Application (Hematology, Diabetes, Nephrology, Oncology), End User (Hospital, POC) - Global Forecast To 2024
발행일 : 2019년 01월 페이지 정보 : 영문 301 Pages

세계의 체외진단(IVD : In Vitro Diagnostics) 시장에 대해 조사 분석했으며, 시장 개요, 부문별 시장 분석, 경쟁 상황, 주요 기업 등의 체계적인 정보를 제공합니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 분석

  • 서론
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
  • 시장 점유율 분석

제5장 세계의 체외진단(IVD) 시장 : 제품별

  • 서론
  • 시약 및 키트
  • 기기
  • 소프트웨어 및 서비스

제6장 세계의 체외진단(IVD) 시장 : 기술별

  • 서론
  • 면역측정
  • 임상화학
  • 분자 진단
  • 미생물학
  • 혈액학
  • 응고 및 지혈
  • 소변 검사
  • 기타

제7장 세계의 체외진단(IVD) 시장 : 적응별

  • 서론
  • 감염증
  • 종양
  • 내분비
  • 당뇨병
  • 심장병
  • 신장병
  • 기타

제8장 세계의 체외진단(IVD) 시장 : 최종사용자별

  • 서론
  • 병원 검사실
  • 독립계 기준 연구소
  • POC 검사
  • 환자 자기 진단
  • 학술·연구기관

제9장 세계의 체외진단(IVD) 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 기타

제10장 경쟁 상황

  • 경쟁 벤치마킹

제11장 기업 개요

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Ortho Clinical Diagnostics(Carlyle Group의 일부)
  • Siemens Healthcare GmbH(Siemens AG의 자회사)
  • Sysmex Corporation
  • Becton, Dickinson And Company
  • Biomerieux SA
  • Diasorin S.P.A.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd

제12장 부록

KSM 19.02.12

List of Tables

  • Table 1 Global IVD Market Drivers: Impact Analysis (2018-2024)
  • Table 2 Global IVD Market Restraints: Impact Analysis (2018-2024)
  • Table 3 Emerging Biomarkers
  • Table 4 Global IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 5 Cost of IVD Reagents and Kits
  • Table 6 Global IVD Reagents and Kits Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 7 Cost of IVD Instruments
  • Table 8 IVD Instruments Provided by The Leading Players
  • Table 9 Global IVD Instruments Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 10 IVD Software Provided by The Leading Players
  • Table 11 Global IVD Software and Services Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 12 Global IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 13 Global Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 14 Global Immunoassay Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 15 Technologies Used in ELISA
  • Table 16 Global ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 17 Global ELISA Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 18 Global Colorimetric Immunoassay Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 19 Global Chemiluminescence Immunoassay Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 20 Global Fluorescence Immunoassay Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 21 Key Rapid Test Analyzers
  • Table 22 Global Rapid Test Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 23 Global Radioimmunoassay Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 24 Global Western Blotting Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 25 Elispot V.S. Conventional ELISA
  • Table 26 Global Enzyme Linked Immunospot Assay Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 27 Key Clinical Chemistry Panel Tests
  • Table 28 Global Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 29 Global Clinical Chemistry Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 30 Global Metabolic Panel Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 31 Electrolyte Panel Analyzers Costs
  • Table 32 Global Electrolyte Panel Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 33 Global Liver Panel Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 34 Global Lipid Profile Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 35 Global Renal Profile Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 36 Global Thyroid Function Panel Market Size, By Technique, 2016-2024 ($ Million)
  • Table 37 Global Molecular Diagnostics Market Size, By Technique, 2016-2024 ($ Million)
  • Table 38 Global Molecular Diagnostics Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 39 Global Polymerase Chain Reaction Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 40 Global Isothermal Nucleic Acid Amplification Technology Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 41 Global Hybridization Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 42 Global DNA Sequencing & NGS Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 43 Global Microarray Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 44 Global IVD Market Size for Microbiology, By Country/Region, 2016-2024 ($ Million)
  • Table 45 Global IVD Market Size for Hematology, By Country/Region, 2016-2024 ($ Million)
  • Table 46 Global Coagulation and Hemostasis Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 47 U.S. Diabetes Indicators, 2016
  • Table 48 Urinalysis Testing Kits and Reagent Costs
  • Table 49 Global Urinalysis Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 50 Global Other IVD Technologies Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 51 IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 52 IVD Products for Infectious Diseases
  • Table 53 IVD Market Size for Infectious Diseases, By Country/Region, 2016-2024 ($ Million)
  • Table 54 IVD Products for Diabetes
  • Table 55 IVD Market Size for Diabetes, By Country/Region, 2016-2024 ($ Million)
  • Table 56 Molecular Diagnostic Products for Oncology
  • Table 57 IVD Market Size for Oncology, By Country/Region, 2016-2024 ($ Million)
  • Table 58 IVD Market Size for Endocrinology, By Country/Region, 2016-2024 ($ Million)
  • Table 59 Key Players Providing IVD Products for Cardiology
  • Table 60 IVD Market Size for Cardiology, By Country/Region, 2016-2024 ($ Million)
  • Table 61 IVD Products for Nephrology
  • Table 62 IVD Market Size for Nephrology, By Country/Region, 2016-2024 ($ Million)
  • Table 63 IVD Products for Autoimmune and Pulmonary Diseases
  • Table 64 IVD Market Size for Other Applications, By Country/Region, 2016-2024 ($ Million)
  • Table 65 Global IVD Market Size, By End Users, 2016-2024 ($ Million)
  • Table 66 Global IVD Market Size for Hospital Laboratories, By Country/Region, 2016-2024 ($ Million)
  • Table 67 Global IVD Market Size for Independent Reference Laboratories, By Country/Region, 2016-2024 ($ Million)
  • Table 68 Global IVD Market Size for PoC Testing, By Country/Region, 2016-2024 ($ Million)
  • Table 69 Global IVD Market Size for Patient Self-Testing, By Country/Region, 2016-2024 ($ Million)
  • Table 70 Global IVD Market Size for Academic And Research Institutes, By Country/Region, 2016-2024 ($ Million)
  • Table 71 Global IVD Market Size, By Country/Region, 2016-2024 ($ Million)
  • Table 72 North America: IVD Market Size, By Country, 2016-2024 ($ Million)
  • Table 73 North America: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 74 North America: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 75 North America: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 76 North America: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 77 North America: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 78 North America: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 79 North America: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 80 North America: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 81 U.S.: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 82 U.S.: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 83 U.S.: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 84 U.S.: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 85 U.S.: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 86 U.S.: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 87 U.S.: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 88 U.S.: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 89 Canada: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 90 Canada: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 91 Canada: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 92 Canada: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 93 Canada: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 94 Canada: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 95 Canada: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 96 Canada: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 97 Europe: IVD Market Size, By Country, 2016-2024 ($Million)
  • Table 98 Europe: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 99 Europe: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 100 Europe: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 101 Europe: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 102 Europe: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 103 Europe: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 104 Europe: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 105 Europe: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 106 Germany: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 107 Germany: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 108 Germany: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 109 Germany: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 110 Germany: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 111 Germany: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 112 Germany: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 113 Germany: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 114 Italy: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 115 Italy: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 116 Italy: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 117 Italy: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 118 Italy: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 119 Italy: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 120 Italy: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 121 Italy: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 122 France: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 123 France: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 124 France: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 125 France: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 126 France: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 127 France: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 128 France: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 129 France: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 130 U.K.: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 131 U.K.: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 132 U.K.: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 133 U.K.: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 134 U.K.: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 135 U.K.: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 136 U.K.: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 137 U.K.: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 138 Spain: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 139 Spain: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 140 Spain: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 141 Spain: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 142 Spain: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 143 Spain: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 144 Spain: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 145 Spain: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 146 Rest of Europe: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 147 Rest of Europe: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 148 Rest of Europe: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 149 Rest of Europe: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 150 Rest of Europe: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 151 Rest of Europe: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 152 Rest of Europe: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 153 Rest of Europe: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 154 Asia Pacific: IVD Market Size, By Country, 2016-2024 ($Million)
  • Table 155 Asia Pacific: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 156 Asia Pacific: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 157 Asia Pacific: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 158 Asia Pacific: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 159 Asia Pacific: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 160 Asia Pacific: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 161 Asia Pacific: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 162 Asia Pacific: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 163 Japan: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 164 Japan: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 165 Japan: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 166 Japan: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 167 Japan: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 168 Japan: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 169 Japan: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 170 Japan: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 171 China: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 172 China: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 173 China: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 174 China: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 175 China: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 176 China: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 177 China: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 178 China: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 179 India: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 180 India: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 181 India: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 182 India: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 183 India: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 184 India: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 185 India: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 186 India: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 187 Australia: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 188 Australia: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 189 Australia: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 190 Australia: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 191 Australia: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 192 Australia: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 193 Australia: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 194 Australia: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 195 South Korea: Leading Infectious Disease Mortalities, 2015
  • Table 196 South Korea: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 197 South Korea: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 198 South Korea: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 199 South Korea: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 200 South Korea: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 201 South Korea: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 202 South Korea: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 203 South Korea: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 204 Rest of Asia Pacific: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 205 Rest of Asia Pacific: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 206 Rest of Asia Pacific: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 207 Rest of Asia Pacific: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 208 Rest of Asia Pacific: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 209 Rest of Asia Pacific: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 210 Rest of Asia Pacific: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 211 Rest of Asia Pacific: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 212 Rest of World: IVD Market Size, By Country, 2016-2024 ($ Million)
  • Table 213 Rest of World: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 214 Rest of World: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 215 Rest of World: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 216 Rest of World: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 217 Rest of World: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 218 Rest of World: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 219 Rest of World: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 220 Rest of World: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 221 Latin America: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 222 Latin America: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 223 Latin America: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 224 Latin America: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 225 Latin America: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 226 Latin America: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 227 Latin America: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 228 Latin America: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 229 Middle East & Africa: IVD Market Size, By Product, 2016-2024 ($ Million)
  • Table 230 Middle East & Africa: IVD Market Size, By Technique, 2016-2024 ($ Million)
  • Table 231 Middle East & Africa: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
  • Table 232 Middle East & Africa: ELISA Market Size, By Type, 2016-2024 ($ Million)
  • Table 233 Middle East & Africa: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
  • Table 234 Middle East & Africa: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
  • Table 235 Middle East & Africa: IVD Market Size, By Application, 2016-2024 ($ Million)
  • Table 236 Middle East & Africa: IVD Market Size, By End User, 2016-2024 ($ Million)
  • Table 237 Number of Developments by the Major Players During 2015-2018
  • Table 238 Key Products: IVD Reagents & Kits
  • Table 239 Key Products: IVD Instruments

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Executives Interviewed
  • Figure 3 Primary Research Techniques
  • Figure 4 Market Size Estimation
  • Figure 5 Key Opportunities
  • Figure 6 Key Adopters Of IVD
  • Figure 7 Immunoassay Technique Dominates the Global IVD Market
  • Figure 8 Cancer/Oncology Expected to Witness A Fastest Growth in The Global IVD Market During 2018-2024
  • Figure 9 Patient Self Testing Expected to Witness A Fastest Growth in The Global IVD Market During 2018-2024
  • Figure 10 Global IVD Market Overview: 2018-2024
  • Figure 11 Global IVD Market, By Geography, 2017
  • Figure 12 Market Dynamics
  • Figure 13 Global Number of Commercially Available Personalized Medicines, 2008-2016
  • Figure 14 Market Share Analysis: IVD Market, 2017
  • Figure 15 Global IVD Market Size, By Product, 2018-2024 ($ Million)
  • Figure 16 Global IVD Market Size, By Technique, 2018-2024 ($ Million)
  • Figure 17 IVD Market Size, By Application, 2018-2024 ($ Million)
  • Figure 18 Global HIV And AIDS Data, 2012-2017
  • Figure 19 Global Number of Cancer Cases, 2018 (In Million)
  • Figure 20 Global IVD Market Size, By End Users, 2018-2024 ($ Million)
  • Figure 21 Volume of CLIA Waived PoCT (Units), 2000-2017,
  • Figure 22 Global Incidence of HIV Infections, 2016 (In Millions)
  • Figure 23 Global IVD Market Size, By Country/Region, 2018-2024 ($ Million)
  • Figure 24 North America: IVD Market Size, By Country/Region, 2018-2024 ($ Million)
  • Figure 25 Europe: IVD Market Size, By Country, 2016-2024 ($ Million
  • Figure 26 Asia Pacific: IVD Market Size, By Country, 2018-2024 ($ Million)
  • Figure 27 India: Number of Healthcare Centers, 1981 To March-2015
  • Figure 28 Rest of World: IVD Market Size, By Country, 2018-2024 ($ Million)
  • Figure 29 Growth Strategies Adopted by The Key Players Between 2015 And 2018
  • Figure 30 IVD Market: Competitive Benchmarking
  • Figure 31 Thermo Fisher Scientific Inc.: Financial Overview (2015-2017)
  • Figure 32 Danaher Corporation: Financial Overview (2015-2017)
  • Figure 33 Abbott Laboratories: Financial Overview (2015-2017)
  • Figure 34 Bio-Rad Laboratories, Inc.:Financial Overview (2015-2017)
  • Figure 35 Siemens Healthcare GmbH: Financial Overview (2015-2017)
  • Figure 36 Financial Overview: Sysmex Corporation (2015-2017)
  • Figure 37 Financial Overview: Becton, Dickinson And Company (2015-2017)
  • Figure 38 Financial Overview: Biomerieux S.A. (2015-2017)
  • Figure 39 Financial Overview: Diasorin S.P.A. (2015-2017)
  • Figure 40 Financial Overview: Qiagen N.V. (2015-2017)
  • Figure 41 Financial Overview: Agilent Technologies, Inc. (2015-2017)
  • Figure 42 Financial Overview: F. Hoffmann-La Roche Ltd (2015-2017)

In Vitro Diagnostics/IVD Market by Product (Reagent, Instruments, Software, Service), Technique [Immunoassay, Clinical Chemistry (Lipids, Renal, Thyroid), PCR], Application (Hematology, Diabetes, Nephrology, Oncology), End User (Hospital, POC) - Global Forecast to 2024

The global IVD market is expected to grow at a CAGR of 5.7% from 2018 to reach $87.21 billion by 2024. The key factors such as rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated instruments by the testing laboratories, and growing interest in companion diagnostics are driving the IVD market. However, unfavorable reimbursement and challenging regulatory scenario in Europe are the major hurdles ahead of the IVD market. On the other hand, development of condition-specific markers and tests and growing demand for IVD products in emerging countries provides significant opportunities for the various stakeholders in this market.

On the basis of product, reagents and kits commanded the largest share of the global IVD market. Also, reagents and kits are expected to witness a rapid growth during the forecast period mainly due to incessant product launches, number of on-going research activities, and growing prevalence of various acute as well as chronic infectious diseases.

On the basis of techniques, molecular diagnostic tests are slated to grow the fastest from 2018 to 2024. According to research from the Wellcome Trust (U.K.) and the U.K. government, ~700,000 people die each year globally from infections that are drug-resistant. If the pace continues, this number is projected to grow to 10 million by 2050. This alarming threat of drug-resistant infections has markedly raised the importance of molecular diagnostics.

Hospital laboratories commanded the largest share of the global IVD market with the rising prevalence of infectious and non-communicable diseases in developing and developed countries, high incidence of hospital-acquired infections (HAIs), significant patient population treated in hospitals, and rising aging population.

An in-depth analysis of the geographic scenario of the industry provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America commanded the largest share of the global IVD market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. The large share of this region is mainly attributed to the remarkably advanced healthcare industry with higher healthcare spending; technological advancements in diagnostic tests; growing investments in personalized medicine; increasing prevalence of chronic diseases; and presence of leading players in the region.

Key players operating in the global IVD market are Roche Diagnostics, Danaher Corporation, Abbott Laboratories, Siemens Healthcare, Thermo Fisher Scientific Inc., Sysmex Corporation, bioMerieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Qiagen N.V., and Agilent Technologies, Inc., among others.

Scope of the Report:

Market by Product

  • Reagents & Kits
  • Instruments
  • Software & Services

Market by Technique

  • Immunoassay
  • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Chemiluminescence Immunoassays
    • Fluorescence Immunoassays
    • Colorimetric Immunoassays
  • Radioimmunoassay
  • Rapid Tests
  • Western Blotting
  • Enzyme-Linked Immunospot Assays
  • Clinical Chemistry
  • Metabolic Panel
  • Electrolyte Panel
  • Liver Panel
  • Lipid Profile
  • Renal Profile
  • Thyroid Function Panel
  • Molecular Diagnostics
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • Microarray
  • Hybridization
  • DNA Sequencing & Next-Generation Sequencing
  • Microbiology
  • Hematology
  • Coagulation and Hemostasis
  • Urinalysis
  • Other IVD Technologies

Market by Application

  • Infectious Diseases
  • Diabetes
  • Cancer/Oncology
  • Endocrinology
  • Cardiology
  • Nephrology
  • Others

Market by End User

  • Hospitals Laboratories
  • Independent Reference Laboratories
  • Point-Of-Care Testing
  • Patient Self-Testing
  • Academic and Research Institutes
  • Acute wound

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Market Ecosystem
  • 1.2. Currency and Limitations
    • 1.2.1. Currency
    • 1.2.2. Limitations
  • 1.3. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Secondary Research
    • 2.1.2. Primary Research
    • 2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Rising Geriatric Population Coupled with the Growing Prevalence of Chronic and Infectious Diseases
    • 4.2.2. Rising Adoption of Fully Automated Instruments and Automation in Laboratories
    • 4.2.3. Growing Adoption of Personalized Medicine
    • 4.2.4. Increasing Adoption of Point-Of-Care (PoC) Testing
  • 4.3. Restraints
    • 4.3.1. Unfavorable Reimbursement Scenario
  • 4.4. Opportunities
    • 4.4.1. Development of Condition-Specific Markers and Tests
    • 4.4.2. Growth Opportunities in Emerging Countries
  • 4.5. Challenges
    • 4.5.1. Changing Regulatory Landscape
    • 4.5.2. Product-Design and Cost Related Challenges In The Uptake Of New Technologies In Developing Countries
    • 4.5.3. Dearth of Qualified Laboratory Technologists
  • 4.6. Market Share Analysis

5. Global In Vitro Diagnostics Market, By Product

  • 5.1. Introduction
  • 5.2. Reagents & Kits
  • 5.3. Instruments
  • 5.4. Software and Services

6. In Vitro Diagnostics Market, By Techniques

  • 6.1. Introduction
  • 6.2. Immunoassay
    • 6.2.1. Enzyme-Linked Immunosorbent Assay
      • 6.2.1.1. Colorimetric Immunoassays
      • 6.2.1.2. Chemiluminescence Immunoassays
      • 6.2.1.3. Fluorescence Immunoassays
    • 6.2.2. Radioimmunoassay
    • 6.2.3. Rapid Tests
    • 6.2.4. Western Blotting
    • 6.2.5. Enzyme-Linked Immunospot Assays
  • 6.3. Clinical Chemistry
    • 6.3.1. Metabolic Panel
    • 6.3.2. Electrolyte Panel
    • 6.3.3. Liver Panel
    • 6.3.4. Lipid Profile
    • 6.3.5. Renal Profile
    • 6.3.6. Thyroid Function Panel
  • 6.4. Molecular Diagnostics
    • 6.4.1. Polymerase Chain Reaction
    • 6.4.2. Isothermal Nucleic Acid Amplification Technology
    • 6.4.3. Microarray
    • 6.4.4. Hybridization
    • 6.4.5. DNA Sequencing & Next-Generation Sequencing
  • 6.5. Microbiology
  • 6.6. Hematology
  • 6.7. Coagulation and Hemostasis
  • 6.8. Urinalysis
  • 6.9. Other IVD Technologies

7. In Vitro Diagnostics Market, by Application

  • 7.1. Introduction
  • 7.2. Infectious Diseases
  • 7.3. Oncology
  • 7.4. Endocrinology
  • 7.5. Diabetes
  • 7.6. Cardiology
  • 7.7. Nephrology
  • 7.8. Other Applications

8. Global In Vitro Diagnostics Market, by End Users

  • 8.1. Introduction
  • 8.2. Hospital Laboratories
  • 8.3. Independent Reference Laboratories
  • 8.4. Point-Of-Care Testing
  • 8.5. Patient Self-Testing
  • 8.6. Academic and Research Institutes

9. In Vitro Diagnostics Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Australia
    • 9.4.5. South Korea
    • 9.4.6. Rest of Asia Pacific
  • 9.5. RoW
    • 9.5.1. Latin America
    • 9.5.2. Middle East and Africa

10. Competitive Landscape

  • 10.1. Competitive Benchmarking

11. Company Profiles

  • 11.1. Thermo Fisher Scientific Inc.
    • 11.1.1. Business Overview
    • 11.1.2. Financial Overview
    • 11.1.3. Product Portfolio
    • 11.1.4. Recent Developments
  • 11.2. Danaher Corporation
    • 11.2.1. Business Overview
    • 11.2.2. Financial Overview
    • 11.2.3. Product Portfolio
    • 11.2.4. Recent Developments
  • 11.3. Abbott Laboratories
    • 11.3.1. Overview
    • 11.3.2. Financial Overview
    • 11.3.3. Product Portfolio
    • 11.3.4. Recent Developments
  • 11.4. Bio-Rad Laboratories, Inc.
    • 11.4.1. Business Overview
    • 11.4.2. Financial Overview
    • 11.4.3. Product Portfolio
    • 11.4.4. Recent Developments
  • 11.5. Ortho Clinical Diagnostics (A Part of Carlyle Group)
    • 11.5.1. Business Overview
    • 11.5.2. Financial Overview
    • 11.5.3. Product Portfolio
    • 11.5.4. Recent Developments
  • 11.6. Siemens Healthcare GmbH (Subsidiary of Siemens AG)
    • 11.6.1. Business Overview
    • 11.6.2. Financial Overview
    • 11.6.3. Product Portfolio
    • 11.6.4. Recent Developments
  • 11.7. Sysmex Corporation
    • 11.7.1. Business Overview
    • 11.7.2. Financial Overview
    • 11.7.3. Product Portfolio
    • 11.7.4. Recent Developments
  • 11.8. Becton, Dickinson And Company
    • 11.8.1. Business Overview
    • 11.8.2. Financial Overview
    • 11.8.3. Product Portfolio
    • 11.8.4. Recent Developments
  • 11.9. Biomerieux SA
    • 11.9.1. Business Overview
    • 11.9.2. Financial Overview
    • 11.9.3. Product Portfolio
    • 11.9.4. Recent Developments
  • 11.10. Diasorin S.P.A.
    • 11.10.1. Business Overview
    • 11.10.2. Financial Overview
    • 11.10.3. Product Portfolio
    • 11.10.4. Recent Development
  • 11.11. Qiagen N.V.
    • 11.11.1. Business Overview
    • 11.11.2. Financial Overview
    • 11.11.3. Product Portfolio
    • 11.11.4. Recent Developments
  • 11.12. Agilent Technologies, Inc.
    • 11.12.1. Business Overview
    • 11.12.2. Financial Overview
    • 11.12.3. Product Portfolio
    • 11.12.4. Recent Developments
  • 11.13. F. Hoffmann-La Roche Ltd
    • 11.13.1. Business Overview
    • 11.13.2. Financial Overview
    • 11.13.3. Product Portfolio
    • 11.13.4. Recent Developments

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization
Back to Top
전화 문의
이용안내
 
BCC Research